OGA and cancer: In this study, we demonstrate that pharmacological perturbation of the proteasome—like that used in cancer treatment— leads to the increased abundance of OGT and OGA in a ribosome-rich fraction, concurrent with O-GlcNAc modification of core translational and ribosome-associated proteins.